I now have comprehensive content from authoritative textbooks. Let me compile the full, detailed explanation of all 5 learning objectives.
Learning Objectives - Full Explanation
LO 1: Prioritized Differential Diagnosis for Acute Anemia + Jaundice in a Child
When a child presents with acute anemia and jaundice, the differential spans hemolytic and non-hemolytic causes. The key is to use the clinical context to prioritize.
Framework: Is the jaundice prehepatic, hepatic, or posthepatic?
- In Miguel's case: elevated indirect bilirubin + normal liver enzymes + cola urine = prehepatic (hemolytic) cause.
Prioritized Differential:
| Priority | Diagnosis | Key Features |
|---|
| 1st | G6PD Deficiency (most likely) | Naphthalene trigger, bite cells, Heinz bodies, negative Coombs, X-linked family Hx |
| 2nd | Autoimmune Hemolytic Anemia (AIHA) | Spherocytes on smear, positive Direct Coombs (DAT) |
| 3rd | Hereditary Spherocytosis (HS) | Spherocytes, elevated MCHC, splenomegaly, osmotic fragility positive |
| 4th | Thalassemia | Microcytic (low MCV), target cells, family history |
| 5th | Sickle Cell Anemia | Sickle/boat-shaped cells on smear |
| Less likely | Infections (malaria, babesiosis) | Travel history, fever, parasites on smear |
| Less likely | TTP/HUS | Schistocytes, thrombocytopenia, renal failure |
In Miguel: MCV is normal (89 fL, ruling out thalassemia), no spherocytes (ruling out HS/AIHA), negative Coombs (ruling out AIHA), no schistocytes (ruling out TTP/HUS). The bite cells + Heinz bodies + naphthalene trigger = G6PD deficiency is #1.
LO 2: Pathophysiology of Oxidative Hemolysis in G6PD Deficiency
This is the biochemical core of the case, beautifully explained via the pentose phosphate pathway (HMP shunt).
Normal RBC Antioxidant Defense:
Glucose → G6P → [G6PD enzyme] → 6-phosphogluconate + NADPH
↓
NADPH → Glutathione reductase
↓
Oxidized Glutathione (GSSG) → Reduced Glutathione (GSH)
↓
GSH + Glutathione Peroxidase → neutralizes H₂O₂ → H₂O
Key principle: RBCs have no mitochondria - the pentose phosphate pathway is their only source of NADPH. NADPH is the currency that keeps glutathione in its reduced (protective) form.
What happens in G6PD Deficiency:
- G6PD enzyme is deficient or unstable → insufficient NADPH produced.
- Without NADPH, glutathione cannot be regenerated in reduced form (GSH).
- RBCs become unable to neutralize reactive oxygen species (H₂O₂, superoxides).
- Oxidative stress (from naphthalene, drugs, infection, fava beans) overwhelms the defense.
- Hemoglobin is oxidized → denatured Hb precipitates as Heinz bodies (visible on supravital staining with methyl violet).
- Heinz bodies are "bitten out" by splenic macrophages → bite cells and blister cells on smear.
- Oxidized RBC membrane becomes rigid → cells are destroyed → intravascular + extravascular hemolysis.
Clinical correlation:
- Hemoglobinuria (cola urine) = free Hb released into plasma and filtered by kidney = intravascular hemolysis.
- Jaundice = unconjugated bilirubin from RBC breakdown.
- Splenomegaly = the spleen removing damaged cells (extravascular component).
- Reticulocytosis (8.2%) = bone marrow compensating by pushing out new RBCs.
(Goldman-Cecil Medicine; Harrison's Principles of Internal Medicine, 22e; Lippincott Biochemistry, 8e)
LO 3: Interpreting CBC, Peripheral Smear, Hemolysis Markers - Including the G6PD Assay Pitfall
CBC Interpretation:
| Finding | Value | Interpretation |
|---|
| Hb 6.2 g/dL | Critically low | Severe anemia - transfusion threshold reached |
| Reticulocyte 8.2% | High (normal 0.5-1.5%) | Hyperproliferative = hemolysis, NOT aplastic/nutritional |
| MCV 89 fL | Normal | Normocytic = not iron deficiency, not thalassemia |
| WBC/Platelets | Normal | No aplastic crisis, no thrombocytopenia, no TTP |
Peripheral Smear Findings:
| Finding | Significance |
|---|
| Bite cells | Splenic pitting of Heinz bodies leaves concave "bites" in RBCs |
| Blister cells | Hb pulled to one side of cell by oxidative membrane damage |
| Heinz bodies (supravital stain) | Denatured precipitated Hb - pathognomonic of oxidative hemolysis |
| Polychromasia | Young reticulocytes released in response to hemolysis |
| No spherocytes | Argues against AIHA and hereditary spherocytosis |
| No schistocytes | Rules out TTP/HUS/microangiopathic hemolytic anemia |
Hemolysis Markers:
| Marker | Result | Mechanism |
|---|
| Indirect bilirubin ↑↑ | 4.1 mg/dL | Heme → unconjugated bilirubin; liver cannot conjugate fast enough |
| LDH ↑↑ | 735 U/L | Released from lysed RBCs (intracellular enzyme) |
| Haptoglobin undetectable | <10 mg/dL | All haptoglobin consumed binding free Hb → saturated |
| Urinalysis: blood 3+, no RBCs | Hemoglobinuria | Free Hb (not intact RBCs) in urine = intravascular hemolysis |
| Coombs (DAT) negative | Normal | No antibodies on RBC surface → rules out immune hemolysis |
The G6PD Assay Pitfall - Exam Favorite!
The G6PD assay returns "Normal/borderline" during the acute episode. This is a false-negative result.
Why?
- G6PD deficiency affects older RBCs most - their enzyme half-life is much shorter (GdA- variant: half-life only 13 days vs. 60 days for normal G6PD).
- During an acute hemolytic crisis, the oldest, most G6PD-deficient cells are preferentially destroyed first.
- What remains in circulation are the young reticulocytes and newly released RBCs, which still have near-normal G6PD activity.
- Reticulocytes have significantly higher G6PD activity than mature RBCs.
- Result: the assay is measuring cells with relatively higher enzyme levels → false normal reading.
Solution: Repeat G6PD assay 4-8 weeks after the acute episode once the reticulocyte surge has subsided and the RBC population has normalized.
(Washington Manual of Medical Therapeutics; Goldman-Cecil Medicine)
LO 4: Distinguishing G6PD Deficiency from AIHA, Hereditary Spherocytosis, and Thalassemia
Targeted Comparison Table:
| Feature | G6PD Deficiency | AIHA | Hereditary Spherocytosis | Thalassemia |
|---|
| Mechanism | Enzyme deficiency → oxidative hemolysis | Autoantibodies destroy RBCs | Defective spectrin/ankyrin → spherical fragile RBCs | Defective globin chain synthesis → ineffective erythropoiesis |
| Inheritance | X-linked recessive | Acquired (idiopathic, SLE, drugs, infections) | Autosomal dominant (usually) | Autosomal recessive |
| Trigger | Oxidants: drugs, naphthalene, fava beans, infection | Spontaneous or cold exposure | Chronic, worsened by infection/splenomegaly | Chronic, lifelong |
| RBC morphology | Bite cells, blister cells, Heinz bodies | Spherocytes | Spherocytes + increased MCHC | Target cells, microcytes, basophilic stippling |
| MCV | Normal (normocytic) | Normal | Normal to slightly decreased | Low (microcytic) |
| Coombs (DAT) | Negative | Positive (IgG warm AIHA) | Negative | Negative |
| Key test | G6PD assay (NOT during crisis!) | Direct Coombs test | Osmotic fragility test; eosin-5-maleimide (EMA) flow cytometry | Hb electrophoresis (HbF↑, HbA2↑) |
| Bilirubin | Indirect ↑ | Indirect ↑ | Indirect ↑ | Indirect ↑ (chronic) |
| Splenomegaly | During acute crisis | Yes | Yes (often prominent) | Yes (massive in beta-thal major) |
| In this case? | YES - all findings fit | Excluded by negative Coombs | Excluded by no spherocytes | Excluded by normal MCV |
Key distinguishing investigation: The Direct Antiglobulin Test (Coombs) is the single most important test to separate immune from non-immune hemolysis.
- Positive DAT = AIHA
- Negative DAT with spherocytes = Hereditary Spherocytosis
- Negative DAT with bite cells/Heinz bodies + oxidant trigger = G6PD deficiency
(Goldman-Cecil Medicine - Blood Smear Table 143-3; Harrison's Principles; Harriet Lane Handbook, 23e)
LO 5: Acute Management Plan + Prevention in the Philippine Setting
Acute Management:
Step 1 - Remove the trigger immediately
- Remove the naphthalene/mothballs from the environment.
- Avoid any further oxidant exposure (see trigger list below).
Step 2 - Supportive care
- IV access, cardiac monitoring (HR 148, compensated but at risk).
- Supplemental O₂ if SpO₂ drops.
- IV fluids to maintain renal perfusion and flush free hemoglobin from tubules (preventing acute kidney injury from hemoglobinuria).
- Monitor urine output closely - hemoglobinuria can cause acute tubular necrosis.
Step 3 - Blood transfusion
- Hb of 6.2 g/dL with tachycardia, tachypnea, and flow murmur = transfusion indicated.
- Most G6PD-deficient episodes are self-limiting once the trigger is removed; however, severe acute anemia requires packed RBC transfusion.
- Target Hb >8-10 g/dL in symptomatic child.
Step 4 - Monitor for complications
- Serial Hb, reticulocyte count.
- Creatinine monitoring (AKI risk from hemoglobinuria).
- The hemolytic episode in G6PD A- variant is typically self-limiting because only the older RBCs are maximally deficient; once those are destroyed, the remaining young cells have enough enzyme to withstand oxidant stress.
Step 5 - Confirmatory testing
- Repeat G6PD assay 4-8 weeks after the acute episode.
- Genetic counseling referral.
Prevention Strategies:
1. Trigger Avoidance (patient/family education)
Triggers to avoid in G6PD-deficient patients:
| Category | Examples |
|---|
| Medications | Primaquine, chloroquine, dapsone, sulfamethoxazole, nitrofurantoin, rasburicase, methylene blue |
| Foods | Fava beans |
| Chemicals | Naphthalene mothballs (the trigger in this case) |
| Other | Infections (most common real-world trigger) |
2. Newborn Screening (Philippine setting)
- The Philippines includes G6PD deficiency in its Expanded Newborn Screening Program (Republic Act 9288), which screens for G6PD along with other metabolic conditions.
- Miguel's mother recalls screening was done but lost the card - this is the real-world challenge.
- In Southeast Asia, the prevalent variant is G6PD Viangchan (Class II - severe); in the Philippines, G6PD Mahidol and G6PD Union are also found. These variants have very low enzyme activity (as low as 0-10% of normal), making clinical disease more severe than the milder G6PD A- variant seen in African populations.
- Early detection through NBS allows trigger avoidance from infancy, preventing hemolytic crises.
3. Genetic Counseling
- G6PD is X-linked recessive - the gene is on the X chromosome (Xq28).
- Miguel is an affected male - he has only one X chromosome carrying the deficient gene (hemizygous).
- His mother is an obligate carrier (her brother also had jaundice as a baby).
- Counseling points:
- All sons of a carrier mother have a 50% chance of being affected.
- All daughters of a carrier mother have a 50% chance of being carriers.
- Daughters can be symptomatic if homozygous or if X-inactivation (lyonization) is unfavorable.
- Fathers with G6PD deficiency will pass the gene to all daughters (who become carriers) but none of their sons (since sons receive the Y chromosome from dad).
- Screen siblings, especially male siblings.
(Goldman-Cecil Medicine; Harrison's Principles of Internal Medicine 22e; Washington Manual of Medical Therapeutics; Lippincott Biochemistry 8e)
Summary Map
TRIGGER (Naphthalene)
↓
G6PD Deficiency → ↓NADPH → ↓GSH → Cannot neutralize oxidative stress
↓
Hb oxidized → Heinz bodies → Bite/blister cells
↓
Intravascular hemolysis → Hemoglobinuria (cola urine)
Extravascular hemolysis → ↑Indirect bilirubin (jaundice)
↓
Hb 6.2, Reticulocytes 8.2%, LDH↑, Haptoglobin↓, DAT negative
↓
G6PD assay falsely NORMAL (reticulocytes dominate) → Repeat in 4-8 weeks
↓
Management: Remove trigger, IV fluids, pRBC transfusion, monitor kidneys
Prevention: Trigger avoidance, NBS, genetic counseling